OPL 22nd Congress 2014 - Program 20-10

THE LEBANESE ORDER OF PHARMACISTS 22nd PHARMACEUTICAL CONGRESS 24 ‐ 25 ‐ 26 October 2014
Hilton Habtoor Grand Hotel – Sin El Fil
Friday 24 October 2014
Chairman and Moderator: Nadia Dalloul
Ch i
d M d t N di D ll l
Topics in Pharmacy
10:00 ‐ 10:30
Use and Misuse of Antibiotics in Populations at Risk (Sanaa Awada) ‐ 0.5 CE
10:30 ‐ 11:00
Medication Considerations in the Pediatric Population (Randa Masri) ‐ 0.5 CE
Coffee Break
11:00 ‐ 11:30
11:30 ‐ 12:00
Tadalafil 5mg Once Daily for the Treatment of Both ED and BPH‐LUTS (Pierre Sarkis) ‐ 0.5 CE
00
30
12:00 ‐ 12:30
y
y
(
)
Pharmacokinetics and Pharmacodynamics of Antimicrobials in the Critically Ill Patient (Rania Lababidi) ‐ 0.5 CE
12:30 ‐ 13:00
La tuberculose: sujet d'actualité au Liban (Myrna Germanos) ‐ 0.5 CE
Ch i
Chairman and Moderator: Latife Karam
d M d t L tif K
Hospital and Clinical Practice
17:00 ‐ 17:30
Clinical and Hospital Pharmacy (Lama Al Hmoud) ‐ 0.5 CE
17:30 ‐ 17:45
Determination of Meropenem Stability over 8 hours in Solutions for IV infusion at Room Temperature and Quantitative/Stability Comparison of Marketed Brands (Omar Tabbouche) ‐ 0.25 CE
17:45 ‐ 18:00
Albumin Misuse And Abuse (Katia Iskandar) ‐ 0.25 CE
Coffee Break
18:00 ‐ 18:30
18:30 ‐ 19:00
(
)
Clinical Scenarios in Parenteral Nutrition (Osama Tabbara) ‐ 0.5 CE
19:00 ‐ 19:30
Survey on Handling Chemotherapy Treatment in Hospitals (Wael Abi Ghanem ‐ Sandra Berberi)
Saturday 25 October 2014
Saturday 25 October 2014
09:00 ‐ 11:00
Opening Ceremony
11:00 ‐ 11:30
Exhibition & Posters Inauguration
11:30 ‐ 12:00
11 30 12 00
Coffee Break
Coffee Break
12:00 ‐ 14:00
Round Table: Medication Safety in the Arab World
Moderator: Rouba El Rassi El Khoury
Lunch Break
Lunch Break
14 00 15 30
14:00 ‐ 15:30
Chairman: Faysal Abed
Moderator: Dalal Hammoudi
Chairman: Mohamed Rhaouti
Moderator: Marianne Abi Fadel
A
Updates in Public Health
B
Career Development Indépendance/autonomie professionelle (Isabelle Adenot)
Indépendance/autonomie professionelle (Isabelle Adenot) ‐ 0.5 CE
Authentification securisée des professionels de santé (Patrick Fortuit) ‐ 0.5 CE
Pharmacist, Ethics and Professional Autonomy (Ema Paulino) ‐ 0.5 CE
Corona Virus Outbreak (Claude Afif) ‐ 0.5 CE
15:30 ‐ 17:00
Les enjeux du médicament vétérinaire (Aline Hajj) ‐ 0.5 CE
Standard of Care Treatment Stage IV Colon Cancer (Fadi Karak) ‐ 0.5 CE
Coffee Break / Poster Presentations
17:00 ‐ 17:30
17:30 ‐ 19:00
Chairman: Hayel Obeidat
Moderator: Pascale Salameh
Chairman: Mohamed Mahyoub Hassan
Moderator: Yolande Saab
A
Safety Considerations
Safety
Considerations
Application of Human Factors in Medication Safety (Rabih Dabliz) ‐ 0.5 CE
Adverse Drug Events Associated with Vitamin K Antagonists: Factors of Therapeutic Imbalance (Amal El Hajje‐Nancy Helou) ‐ 0.5 CE
B
Management in Perspective
Management
in Perspective
NICE Clinical Guideline on Medicines Adherence CG 76 (Mahendra Patel) ‐ 0.5 CE
L
Les complications toxiques des anticorps monoclonaux li ti
t i
d
ti
l
utilisés en thérapeutique (Diane Antonios) ‐ 0.5 CE
O
Opportunities & Challenges in the Use of Pharmacy t iti & Ch ll
i th U
f Ph
Technology (Osama Tabbara) ‐ 0.5 CE
Emerging Hub for Pharmacoeconomics: The Jordanian Experience (Ibrahim Alabbadi) ‐ 0.5 CE
Sunday 26 October 2014
09:30 ‐ 11:00
APSO Global Solution for Counterfeit Medicines (Room B)
11:00 ‐ 11:30
Coffee Break / Poster Presentations
Chairman: Marc Antoine Zablith
Moderator: Zeina Berjawi
A
Medical Laboratory
Le syndrome métabolique (Salam Samad) ‐ 0.5 CE
11:30 ‐ 13:00
11:30 13:00
Surveillance biologique de la femme enceinte (Marie‐
Gabrielle Ghorra) ‐ 0.5 CE
La résistance aux antibiotiques (Dolla Karam Sarkis) ‐ 0.5 CE
Chairman: Ibrahim Alabbadi Moderator: Diana Charbel
C
Regulatory Affairs
Good Storage and Distribution Practices (Christelle Françaoui) ‐ 0.5 CE JFDA in brief (Hayel Obeidat) ‐ 0.5 CE
Chairman: Ahmad Eissa
Moderator: Ahmad Yazibi
B
Counseling Corner
I
Iron in Infant Nutrition: What is the Evidence in 2014? i I f t N t iti
Wh t i th E id
i 2014?
(Antoine Farah) ‐ 0.5 CE
Stability of Pharmaceutical Products: Role of the Pharmacist (Mohamad Issa) ‐ 0.5 CE
Pharmacist (Mohamad Issa) 0 5 CE
Drugs and Nutrients Consideration after Bariatric Surgery (Marwan Akel) ‐ 0.5 CE
(Marwan Akel) 0 5 CE
UTI Treatment in Community Practice (Jihane Safwan) ‐ 0.5 CE
Coffee Break
Chairman: Ibrahim Al Joundi
Moderator: Loma Machmouchi
Chairman: Fares Al Chaar
Moderator: Soha Sinno
A
Pharmaceutical Sciences
B
Metabolic Disorders: New Guidelines
Updates in Diabetes: GLP1 Analogues and Insulin (Akram Echtay) ‐ 0.5 CE
Updates on Hypertension Guidelines: “A Glance on the JNC 8” (Lama Soubra) ‐ 0.5 CE
Cholesterol Management: State of the Art 2014 (Faraj
Cholesterol Management: State of the Art 2014 (Faraj Saade) ‐ 0.5 CE
La pharmacologie du placebo (Lydia Khabbaz) ‐ 0.5 CE
18:30 ‐ 19:30
Hyperhydrosis: The Silent Handicap (Hany Abi Ghosn) ‐ 0.5 CE
A
Updates in Pharmacy Practice
Les prescriptions anti‐inflammatoires et anti‐infectieuses p
p
en dentisterie (Nada Farhat Mouchayleh‐Jeanine Gebeily) ‐ 0.5 CE
Polycystic Ovary Syndrome Overview (Mona Nasrallah) ‐ 0.5 CE
16:00 ‐ 16:30
18:00 ‐ 18:30
Emollient Updates (Amal Mehanna) ‐ 0.5 CE
Lunch Break
Chairman: Abdelkarim Hamrouni
Moderator: Nayla Sargi
16:30 ‐ 18:00
B
Dermatology in Pharmacy Practice
Regulatory Overview in KSA (Abdullah Almesned) ‐ 0.5 CE Hair Loss (Jasmin Abdelbaki) ‐ 0.5 CE
13:00 ‐ 14:30
14:30 ‐ 16:00
Chairman: Maryam Kaldari
Moderator: Sabine Helou
Hormesis: A Revolutionnary Approach to Pharmacology (Krikor Sahakian) ‐ 0.5 CE
Dry Eyes More than just Reduced Tears! (Mohamed
Dry Eyes… More than just Reduced Tears! (Mohamed Khalifeh) ‐ 0.5 CE
Coffee Break
Closing Ceremony ‐ General Discussion & Recall of Scientific Decision
Together Towards a Brighter Future: OPL 2013‐2014 Updates (Rabih Hassouneh)
Together Towards a Brighter Future: OPL 2013‐2014 Updates (Rabih Hassouneh)